Skye Bioscience Inc (SKYE)
5.53
+0.21
(+3.95%)
USD |
NASDAQ |
Nov 14, 16:00
5.53
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Total Liabilities (Quarterly): 5.732M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.732M |
| June 30, 2024 | 14.45M |
| March 31, 2024 | 15.95M |
| December 31, 2023 | 14.07M |
| September 30, 2023 | 13.91M |
| June 30, 2023 | 10.03M |
| March 31, 2023 | 9.368M |
| December 31, 2022 | 12.12M |
| September 30, 2022 | 6.154M |
| June 30, 2022 | 5.269M |
| March 31, 2022 | 4.238M |
| December 31, 2021 | 3.991M |
| September 30, 2021 | 3.422M |
| June 30, 2021 | 3.217M |
| March 31, 2021 | 2.92M |
| December 31, 2020 | 2.221M |
| September 30, 2020 | 2.496M |
| June 30, 2020 | 3.322M |
| March 31, 2020 | 2.376M |
| December 31, 2019 | 1.449M |
| September 30, 2019 | 18.13M |
| June 30, 2019 | 14.72M |
| March 31, 2019 | 32.59M |
| December 31, 2018 | 17.52M |
| Date | Value |
|---|---|
| September 30, 2018 | 11.32M |
| June 30, 2018 | 10.29M |
| March 31, 2018 | 8.912M |
| December 31, 2017 | 1.357M |
| September 30, 2017 | 2.448M |
| June 30, 2017 | 2.262M |
| March 31, 2017 | 1.847M |
| December 31, 2016 | 1.774M |
| September 30, 2016 | 1.711M |
| June 30, 2016 | 1.337M |
| March 31, 2016 | 3.360M |
| December 31, 2015 | 3.040M |
| September 30, 2015 | 3.515M |
| June 30, 2015 | 1.682M |
| March 31, 2015 | 0.8071M |
| December 31, 2014 | 0.8019M |
| September 30, 2014 | 0.3495M |
| July 31, 2014 | 0.0865M |
| April 30, 2014 | 0.0493M |
| January 31, 2014 | 0.0538M |
| October 31, 2013 | 0.0623M |
| July 31, 2013 | 0.0642M |
| April 30, 2013 | 0.0688M |
| October 31, 2012 | 0.0043M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.449M
Minimum
Dec 2019
15.95M
Maximum
Mar 2024
6.835M
Average
4.753M
Median
Total Liabilities (Quarterly) Benchmarks
| Oramed Pharmaceuticals Inc | 8.069M |
| Viking Therapeutics Inc | 26.44M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 81.54M |
| Shareholders Equity (Quarterly) | 75.80M |